The latest NHS figures reveal waiting lists for planned treatments in England have surged to 7.4 million, raising concerns over healthcare access. Despite a slight improvement in patient wait times, targets remain unmet as the government sets new milestones for trusts.
The US military's follow-up strikes on a drug vessel in the Caribbean raise serious legal and ethical questions. With a death toll of 11, concerns mount over the treatment of survivors and the legality of the operations.
President Trump has come under fire for his recent derogatory remarks towards female journalists, sparking a debate about press freedom and respect in the media landscape. His comments have drawn widespread criticism and raised questions about his treatment of the press.
In a heartfelt essay, Tatiana Schlossberg, granddaughter of JFK, shares her devastating cancer diagnosis and the impact on her family. As she battles acute myeloid leukemia, her story sheds light on both personal and political struggles.
In a groundbreaking decision, the FDA has lifted the black box warnings on hormone replacement therapy for menopause, potentially improving access for women seeking relief from menopausal symptoms.
The FDA has removed black box warnings on estrogen treatments for menopause, igniting a debate about the benefits and risks of hormone therapy. Dr. Marty Makary discusses the implications for women's health.
Exciting developments in Alzheimer's research reveal that two existing drugs may reverse brain damage in mice, offering hope for future human trials as awareness grows ahead of the Walk to End Alzheimer’s.
Diane Davis faced a devastating ovarian cancer diagnosis, but a surprising Lynch syndrome discovery and immunotherapy gave her a new lease on life. Discover her inspiring journey of resilience and hope!
Discover how a groundbreaking gene-editing technology is revolutionizing cholesterol management, potentially eliminating the need for daily medication. This breakthrough, while still in early stages, emphasizes the importance of healthy habits for heart health.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.